$XWEL
XWELL Inc

2014 Q1 Form 10-Q Financial Statement

#000114420414028600 Filed on May 08, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1 2011 Q2
Revenue $250.0K $0.00 $227.0K
YoY Change -100.0% 467.5%
Cost Of Revenue $4.880M $6.681M $45.00K
YoY Change -26.96% 434.05% 50.0%
Gross Profit -$4.630M -$6.681M $182.0K
YoY Change -30.7% 483.49% 1720.0%
Gross Profit Margin -1852.0% 80.18%
Selling, General & Admin $4.243M $3.991M $1.375M
YoY Change 6.31% 547.89% 20.61%
% of Gross Profit 755.49%
Research & Development $225.0K $270.0K $460.0K
YoY Change -16.67% -23.33%
% of Gross Profit 252.75%
Depreciation & Amortization $960.0K $840.0K $30.00K
YoY Change 14.29% 0.0%
% of Gross Profit 16.48%
Operating Expenses $4.468M $4.261M $1.835M
YoY Change 4.86% 591.72% 5.46%
Operating Profit -$9.825M -$10.50M -$1.653M
YoY Change -6.42% 295.29% -4.45%
Interest Expense -$1.080M -$380.0K -$780.0K
YoY Change 184.21% -72.92%
% of Operating Profit
Other Income/Expense, Net $1.000K $20.00K -$10.00K
YoY Change -95.0% -200.0%
Pretax Income -$10.90M -$10.86M -$1.478M
YoY Change 0.38% 93.08% -67.8%
Income Tax $0.00 $0.00 $26.00K
% Of Pretax Income
Net Earnings -$11.11M -$11.96M -$1.504M
YoY Change -7.15% 111.98% -67.38%
Net Earnings / Revenue -4443.6% -662.56%
Basic Earnings Per Share -$0.13 -$0.15
Diluted Earnings Per Share -$0.13 -$0.15 -$150.0M
COMMON SHARES
Basic Shares Outstanding 85.46M shares 82.39M shares 5.756M shares
Diluted Shares Outstanding 85.46M shares 82.39M shares

Balance Sheet

Concept 2014 Q1 2013 Q1 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.80M $52.20M $400.0K
YoY Change -46.74% 1350.0% -95.88%
Cash & Equivalents $27.82M $49.13M $0.00
Short-Term Investments $3.100M
Other Short-Term Assets $729.0K $200.0K $1.300M
YoY Change 264.5% 100.0% 550.0%
Inventory
Prepaid Expenses
Receivables $100.0K $200.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $28.55M $52.60M $1.900M
YoY Change -45.73% 1239.79% -80.61%
LONG-TERM ASSETS
Property, Plant & Equipment $118.0K $300.0K $200.0K
YoY Change -60.67% 125.56% 0.0%
Goodwill $65.76M
YoY Change
Intangibles $21.79M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.034M $0.00 $0.00
YoY Change -100.0%
Total Long-Term Assets $88.70M $99.10M $200.0K
YoY Change -10.49% 70183.69% -33.33%
TOTAL ASSETS
Total Short-Term Assets $28.55M $52.60M $1.900M
Total Long-Term Assets $88.70M $99.10M $200.0K
Total Assets $117.2M $151.7M $2.100M
YoY Change -22.71% 3630.02% -79.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.700M $3.600M $400.0K
YoY Change -25.0% 500.0% -50.0%
Accrued Expenses $200.0K $500.0K $300.0K
YoY Change -60.0% 25.0% -25.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $1.100M
YoY Change -8.33%
Total Short-Term Liabilities $2.928M $4.100M $1.900M
YoY Change -28.59% 238.84% -17.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $32.00K $7.900M $1.900M
YoY Change -99.59% 338.89% -26.92%
Total Long-Term Liabilities $32.00K $7.900M $1.900M
YoY Change -99.59% 330.28% -63.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.928M $4.100M $1.900M
Total Long-Term Liabilities $32.00K $7.900M $1.900M
Total Liabilities $2.960M $12.00M $3.800M
YoY Change -75.33% 293.96% -49.33%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $865.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $109.9M $139.7M $0.00
YoY Change
Total Liabilities & Shareholders Equity $117.2M $151.7M $2.100M
YoY Change -22.71% 3630.02% -79.21%

Cashflow Statement

Concept 2014 Q1 2013 Q1 2011 Q2
OPERATING ACTIVITIES
Net Income -$11.11M -$11.96M -$1.504M
YoY Change -7.15% 111.98% -67.38%
Depreciation, Depletion And Amortization $960.0K $840.0K $30.00K
YoY Change 14.29% 0.0%
Cash From Operating Activities -$8.493M -$4.872M -$1.400M
YoY Change 74.32% 300.99% 30.84%
INVESTING ACTIVITIES
Capital Expenditures $72.00K $28.00K -$20.00K
YoY Change 157.14% 460.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$3.110M -$1.050M
YoY Change -100.0%
Cash From Investing Activities -$72.00K -$3.140M -$1.070M
YoY Change -97.71% 62700.0% 10600.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.796M $174.0K -680.0K
YoY Change 1506.9% -95.24% -107.28%
NET CHANGE
Cash From Operating Activities -$8.493M -$4.872M -1.400M
Cash From Investing Activities -$72.00K -$3.140M -1.070M
Cash From Financing Activities $2.796M $174.0K -680.0K
Net Change In Cash -$5.769M -$7.838M -3.150M
YoY Change -26.4% -422.29% -138.14%
FREE CASH FLOW
Cash From Operating Activities -$8.493M -$4.872M -$1.400M
Capital Expenditures $72.00K $28.00K -$20.00K
Free Cash Flow -$8.565M -$4.900M -$1.380M
YoY Change 74.8% 301.64% 30.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Other Assets Current
OtherAssetsCurrent
729000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5488000 USD
CY2013Q1 us-gaap Revenues
Revenues
0 USD
CY2014Q1 us-gaap Revenues
Revenues
250000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33586000 USD
CY2014Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
4359000 USD
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
865000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
845000 USD
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
196200000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
189465000 USD
CY2014Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
87137000 USD
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
76028000 USD
CY2013Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
43000 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
109928000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
114282000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
117247000 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
28547000 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
118000 USD
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21791000 USD
CY2014Q1 us-gaap Goodwill
Goodwill
65757000 USD
CY2013Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
4040000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
299000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27818000 USD
CY2014Q1 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
0 USD
CY2013Q4 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
787000 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
455000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
34828000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
230000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
65757000 USD
CY2014Q1 us-gaap Assets
Assets
117247000 USD
CY2014Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2650000 USD
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
224000 USD
CY2014Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
54000 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2928000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
123810000 USD
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
84502653 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86458959 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
84502653 shares
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><i>b) Use of estimates</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from such estimates. Significant items subject to such estimates and assumptions include the valuation of the assets acquired and the liabilities assumed as part of the Merger, the useful lives of the Company&#8217;s tangible and intangible assets, the valuation of the Company&#8217;s derivative warrants, the valuation of stock-based compensation, the valuation of goodwill, deferred tax assets and liabilities, income tax uncertainties and other contingencies.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q1 us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i>(f) Derivative instruments</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company recognizes all derivative instruments as either assets or liabilities in the consolidated balance sheets at their respective fair values. The Company's derivative instruments include its Special Bridge Warrants, Conversion Warrants, Preferential Reload Warrants and certain of its Series 1 Warrants (as defined in Note 8), all of which have been recorded as a liability at fair value, and are revalued at each reporting date, with changes in the fair value of the instruments included in the consolidated statements of operations as non-operating income (expense).</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i>(j) Reclassification</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i>&#160;</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain balances have been reclassified to conform to presentation requirements including discontinued operations.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86458959 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27048986 shares
us-gaap Revenues
Revenues
1450000 USD
CY2013Q1 us-gaap Legal Fees
LegalFees
5399000 USD
CY2014Q1 us-gaap Legal Fees
LegalFees
4875000 USD
us-gaap Legal Fees
LegalFees
37708000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
270000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
225000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2280000 USD
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
33778695 shares
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29945191 shares
CY2014Q1 vrng Percentage Of Interest Owned Reverse Acquisition Transaction
PercentageOfInterestOwnedReverseAcquisitionTransaction
0.6761 pure
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3991000 USD
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4018000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30759000 USD
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
10499000 USD
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
10075000 USD
us-gaap Costs And Expenses
CostsAndExpenses
77169000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10499000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9825000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-75719000 USD
CY2013Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
17000 USD
CY2014Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
269000 USD
CY2013Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1000 USD
CY2014Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
5000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
53000 USD
CY2013Q1 vrng Income Loss From Issuance Of Inducement Warrants
IncomeLossFromIssuanceOfInducementWarrants
0 USD
CY2014Q1 vrng Income Loss From Issuance Of Inducement Warrants
IncomeLossFromIssuanceOfInducementWarrants
0 USD
vrng Income Loss From Issuance Of Inducement Warrants
IncomeLossFromIssuanceOfInducementWarrants
-2883000 USD
CY2013Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-376000 USD
CY2014Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1076000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
4575000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10859000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10900000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-73811000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-10859000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-10900000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-73811000 USD
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-13014000 USD
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
312000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-13326000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-11964000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-11109000 USD
us-gaap Net Income Loss
NetIncomeLoss
-87137000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.13
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.13
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.39
CY2013Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.02
CY2014Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.00
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.25
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.64
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.13
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.13
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.39
CY2013Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.02
CY2014Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.00
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.25
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.64
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82389353 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85457670 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53255928 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82389353 shares
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85457670 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54752466 shares
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
530000 USD
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
6266000 USD
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-1080000 USD
CY2014Q1 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-229000 USD
us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-12989000 USD
CY2014Q1 us-gaap Disposal Group Including Discontinued Operation Other Income
DisposalGroupIncludingDiscontinuedOperationOtherIncome
20000 USD
us-gaap Disposal Group Including Discontinued Operation Other Income
DisposalGroupIncludingDiscontinuedOperationOtherIncome
-25000 USD
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3094000 USD
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2800000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23454000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6422000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5465000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28213000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28213000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21791000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22748000 USD
CY2014Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P8Y3M18D
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
2586000 USD
CY2014Q1 vrng Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long Term Deposit
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDeposit
8000 USD
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
124000 USD
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
10133000 USD
CY2014Q1 vrng Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill
65965000 USD
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
78816000 USD
CY2014Q1 vrng Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long Term Derivative Liability
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDerivativeLiability
3162000 USD
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
3162000 USD
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
75654000 USD
CY2014Q1 vrng Business Combination Consideration Transferred Stock Options Granted
BusinessCombinationConsiderationTransferredStockOptionsGranted
7364000 USD
CY2014Q1 vrng Business Combination Consideration Transferred Warrants Granted
BusinessCombinationConsiderationTransferredWarrantsGranted
10079000 USD
CY2014Q1 vrng Business Combination Consideration Transferred Equity Interests Issued And Penny Options Granted
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndPennyOptionsGranted
58211000 USD
CY2014Q1 vrng Business Acquisitions Cost Of Acquired Entity Purchase Price
BusinessAcquisitionsCostOfAcquiredEntityPurchasePrice
75654000 USD
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
463000 USD
CY2012Q3 vrng Business Acquisition Purchases Price Allocation Assets Acquired Liabilities Assumed Net
BusinessAcquisitionPurchasesPriceAllocationAssetsAcquiredLiabilitiesAssumedNet
75654000 USD
CY2012Q3 vrng Adjustments To Additional Paid In Capital Net Fair Value Of Warrant Issued
AdjustmentsToAdditionalPaidInCapitalNetFairValueOfWarrantIssued
21954000 USD
CY2013Q4 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
48000 USD
CY2013Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
102000 USD
CY2013Q4 us-gaap Disposal Group Including Discontinued Operation Goodwill
DisposalGroupIncludingDiscontinuedOperationGoodwill
0 USD
CY2013Q4 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Net
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNet
637000 USD
CY2013Q4 us-gaap Goodwill Gross
GoodwillGross
208000 USD
CY2013 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
208000 USD
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
65000 USD
CY2014Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
37000 USD
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
1145000 USD
CY2014Q1 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
266000 USD
CY2013Q1 vrng Disposal Group Including Discontinued Operation Impairment Loss
DisposalGroupIncludingDiscontinuedOperationImpairmentLoss
0 USD
CY2014Q1 vrng Disposal Group Including Discontinued Operation Impairment Loss
DisposalGroupIncludingDiscontinuedOperationImpairmentLoss
0 USD
vrng Disposal Group Including Discontinued Operation Impairment Loss
DisposalGroupIncludingDiscontinuedOperationImpairmentLoss
7253000 USD
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Other Income
DisposalGroupIncludingDiscontinuedOperationOtherIncome
-9000 USD
CY2013Q4 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
7253000 USD
CY2014Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
4413000 USD
CY2013Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
4083000 USD
CY2011Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0 USD
CY2011Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0 USD
CY2012 vrng Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Recorded In Connection With Merger
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRecordedInConnectionWithMerger
21954000 USD
CY2012 vrng Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Derivative Warrants Issued By Legal Parent
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityDerivativeWarrantsIssuedByLegalParent
3162000 USD
CY2013 vrng Fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityderivativewarrantsremoval
Fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityderivativewarrantsremoval
2300000 USD
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
156000 USD
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
9000 USD
CY2014Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
210000 USD
CY2012 vrng Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Exercise Of Derivative Warrants
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExerciseOfDerivativeWarrants
10657000 USD
CY2013 vrng Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Exercise Of Derivative Warrants
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExerciseOfDerivativeWarrants
808000 USD
CY2014Q1 vrng Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Exercise Of Derivative Warrants
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExerciseOfDerivativeWarrants
746000 USD
CY2012 vrng Fair Value Measurement Adjusted In Earnings
FairValueMeasurementAdjustedInEarnings
7003000 USD
CY2013 vrng Fair Value Measurement Adjusted In Earnings
FairValueMeasurementAdjustedInEarnings
430000 USD
CY2014Q1 vrng Fair Value Measurement Adjusted In Earnings
FairValueMeasurementAdjustedInEarnings
-866000 USD
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7612000 USD
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4083000 USD
CY2014Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4413000 USD
CY2014Q1 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2014Q1 vrng Fair Value Inputs Probability Of Achieving Target
FairValueInputsProbabilityOfAchievingTarget
0.05 pure
CY2014Q1 vrng Fair Value Assumptions Timing Of Down Round Triggering Event
FairValueAssumptionsTimingOfDownRoundTriggeringEvent
December 2014
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16972977 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81889226 shares
CY2011Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
0 shares
CY2012 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
890192 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
8768014 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
265000 shares
CY2012 vrng Legal Parents Shares Of Common Stock Recorded Upon Merger
LegalParentsSharesOfCommonStockRecordedUponMerger
15206118 shares
CY2012 vrng Waarrants Issued And Exercised
WaarrantsIssuedAndExercised
754400 shares
CY2012 vrng Waarrants Issued And Exercised Before Merger
WaarrantsIssuedAndExercisedBeforeMerger
6832150 shares
CY2013 vrng Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
435783 shares
CY2014Q1 vrng Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
718766 shares
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
726346 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2177644 shares
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1237540 shares
CY2012Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
20136445 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8204963 shares
CY2012 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
160600 shares
CY2012 vrng Class Of Warrant Or Right Exercise
ClassOfWarrantOrRightExercise
250000 shares
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2012 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
76000 USD
vrng Adjustment To Additonal Paid In Capital Issuance Of Shares In Financing Round One
AdjustmentToAdditonalPaidInCapitalIssuanceOfSharesInFinancingRoundOne
5145000 USD
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8087000 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12093000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
474000 USD
CY2012 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
54961000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2883000 USD
CY2012 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0 USD
CY2012 vrng Adjustments To Additional Paid In Capital Warrant Exercised
AdjustmentsToAdditionalPaidInCapitalWarrantExercised
22932000 USD
CY2013 vrng Adjustments To Additional Paid In Capital Warrant Exercised
AdjustmentsToAdditionalPaidInCapitalWarrantExercised
1398000 USD
CY2014Q1 vrng Adjustments To Additional Paid In Capital Warrant Exercised
AdjustmentsToAdditionalPaidInCapitalWarrantExercised
2011000 USD
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
509000 USD
CY2013 vrng Adjustments To Additional Paid In Capital Conversion Of Derivative Warrants Into Equity Warrants
AdjustmentsToAdditionalPaidInCapitalConversionOfDerivativeWarrantsIntoEquityWarrants
3918000 USD
CY2012 vrng Adjustment To Additonal Paid In Capital Issuance Of Shares In Financing Round Three
AdjustmentToAdditonalPaidInCapitalIssuanceOfSharesInFinancingRoundThree
31148000 USD
CY2012 vrng Stock Issued During Period For Patents
StockIssuedDuringPeriodForPatents
750000 USD
CY2012 vrng Adjustment To Additonal Paid In Capital Issuance Of Shares In Financing Round Two
AdjustmentToAdditonalPaidInCapitalIssuanceOfSharesInFinancingRoundTwo
44962000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-20841000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-52433000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2754000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
148332000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
2865000 USD
CY2013Q4 vrng Share Based Compensation Arrangement By Share Based Payment Award Options Vested Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOptionsOutstandingNumber
10457159 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1025000 shares
CY2014Q1 vrng Share Based Compensation Arrangement Award Options Exercised
ShareBasedCompensationArrangementAwardOptionsExercised
970001 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
66166 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
93750 shares
CY2014Q1 vrng Share Based Compensations Arrangement By Share Based Payment Award Options Vested Options Outstanding Number
ShareBasedCompensationsArrangementByShareBasedPaymentAwardOptionsVestedOptionsOutstandingNumber
10352242 shares
CY2014Q1 vrng Share Based Compensation Arrangement By Share Based Payment Award Vested Options Forfeited Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedOptionsForfeitedWeightedAverageGrantDateFairValue
2.20
CY2013Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-4000 USD
CY2014Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-20000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
5716131 shares
CY2014Q1 vrng Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period After Merger Exercise Price Range
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAfterMergerExercisePriceRange
4.10
CY2014Q1 vrng Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Exercise Price Range
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodExercisePriceRange
3.72
CY2013Q4 vrng Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageGrantDateFairValue
2.50
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.21
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.42
CY2014Q1 vrng Share Based Compensation Arrangement By Share Based Payment Award Vested Options Expired Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedOptionsExpiredWeightedAverageGrantDateFairValue
2.48
CY2013Q4 vrng Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested Other Than Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedOtherThanOptionsOutstandingWeightedAverageGrantDateFairValue
2.32
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
18427478 shares
CY2014Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
17708712 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
3.15
CY2014Q1 vrng Class Of Warrant Or Right Exercises In Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisesInPeriodExercisePriceOfWarrantsOrRights
1.76
CY2014Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
3.21
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
5.06
CY2012Q4 vrng Expected Term Of Warrants
ExpectedTermOfWarrants
P2Y7M28D
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2173852 shares
CY2014Q1 vrng Litigation Settlement Amount Description
LitigationSettlementAmountDescription
According to the agreement, Microsoft Corporation paid the Company $1,000 and agreed to pay 5% of any future amount Google pays for its use of the patents acquired from Lycos.
CY2014Q1 vrng Adjustments To Additional Paid In Capital Net Fair Value Of Warrant Issued
AdjustmentsToAdditionalPaidInCapitalNetFairValueOfWarrantIssued
21954000 USD
CY2013Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
53000 USD
CY2014Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
112000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
473000 USD
CY2014Q1 vrng Revocation Proceeding Value
RevocationProceedingValue
1700000 USD
CY2013Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1281000 USD
CY2014Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1141000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9191000 USD
CY2013Q1 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
CY2014Q1 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
7253000 USD
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-58000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3094000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2800000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
23454000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
2883000 USD
CY2013Q1 vrng Assignment Of Patents
AssignmentOfPatents
0 USD
CY2014Q1 vrng Assignment Of Patents
AssignmentOfPatents
0 USD
vrng Assignment Of Patents
AssignmentOfPatents
100000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
69000 USD
CY2013Q1 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-109000 USD
CY2014Q1 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-139000 USD
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
230000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2228000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2560000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1434000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4872000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8493000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-47954000 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
72000 USD
us-gaap Interest Paid
InterestPaid
17000 USD
CY2013Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
3000 USD
CY2014Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
312000 USD
CY2013Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2014Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
27364000 USD
CY2013Q1 us-gaap Payments For Deposits
PaymentsForDeposits
-8000 USD
CY2014Q1 vrng Proceeds From Issuance Of Common Stock Two
ProceedsFromIssuanceOfCommonStockTwo
0 USD
CY2014Q1 us-gaap Payments For Deposits
PaymentsForDeposits
0 USD
us-gaap Payments For Deposits
PaymentsForDeposits
239000 USD
CY2013Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3140000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-72000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24589000 USD
CY2013Q1 vrng Proceeds From Issuance Of Common Stock One
ProceedsFromIssuanceOfCommonStockOne
0 USD
CY2014Q1 vrng Proceeds From Issuance Of Common Stock One
ProceedsFromIssuanceOfCommonStockOne
0 USD
vrng Proceeds From Issuance Of Common Stock One
ProceedsFromIssuanceOfCommonStockOne
31148000 USD
CY2013Q1 vrng Proceeds From Issuance Of Common Stock Two
ProceedsFromIssuanceOfCommonStockTwo
0 USD
vrng Proceeds From Issuance Of Common Stock Two
ProceedsFromIssuanceOfCommonStockTwo
44962000 USD
CY2013Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 USD
CY2014Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 USD
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 USD
CY2013Q1 vrng Proceeds From Mezzanine Preferred Stock
ProceedsFromMezzaninePreferredStock
0 USD
CY2014Q1 vrng Proceeds From Mezzanine Preferred Stock
ProceedsFromMezzaninePreferredStock
0 USD
vrng Proceeds From Mezzanine Preferred Stock
ProceedsFromMezzaninePreferredStock
1800000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5145000 USD
CY2013Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
9000 USD
CY2014Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1531000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3014000 USD
CY2013Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
165000 USD
CY2014Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1265000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
14130000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
174000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2796000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
100199000 USD
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
6000 USD
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
162000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7832000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5768000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
27818000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56960000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49128000 USD
CY2013Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
41000 USD
CY2013Q1 vrng Purchase Patents
PurchasePatents
0 USD
CY2014Q1 vrng Purchase Patents
PurchasePatents
0 USD
vrng Purchase Patents
PurchasePatents
750000 USD
CY2013Q1 vrng Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Prior To Merger
ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPriorToMerger
0 USD
CY2014Q1 vrng Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Prior To Merger
ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPriorToMerger
0 USD
vrng Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Prior To Merger
ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPriorToMerger
76000 USD
vrng Conversion Of Preferred Stock Into Common Stock Upon Merger
ConversionOfPreferredStockIntoCommonStockUponMerger
1724000 USD
CY2013Q1 vrng Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Post Merger
ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPostMerger
0 USD
CY2014Q1 vrng Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Post Merger
ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPostMerger
0 USD
vrng Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Post Merger
ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPostMerger
201000 USD
vrng Total Cash Acquired During Acquisition
TotalCashAcquiredDuringAcquisition
3326000 USD
CY2013Q1 vrng Conversion Of Preferred Stock Into Common Stock Upon Merger
ConversionOfPreferredStockIntoCommonStockUponMerger
0 USD
CY2014Q1 vrng Conversion Of Preferred Stock Into Common Stock Upon Merger
ConversionOfPreferredStockIntoCommonStockUponMerger
0 USD
CY2014Q1 vrng Conversion Of Derivative Warrant Into Common Stock
ConversionOfDerivativeWarrantIntoCommonStock
746000 USD
CY2014Q1 us-gaap Business Acquisition Share Price
BusinessAcquisitionSharePrice
0.01
CY2013Q1 vrng Conversion Of Derivative Warrant Into Common Stock
ConversionOfDerivativeWarrantIntoCommonStock
69000 USD
CY2014Q1 dei Document Type
DocumentType
10-Q
vrng Noncash Or Part Noncash Acquisition Fair Value Of Warrants Acquired
NoncashOrPartNoncashAcquisitionFairValueOfWarrantsAcquired
17443000 USD
us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
3162000 USD
CY2014Q2 vrng Litigation Settlement Deposit Amount
LitigationSettlementDepositAmount
1400000 USD
vrng Conversion Of Derivative Warrant Into Common Stock
ConversionOfDerivativeWarrantIntoCommonStock
12221000 USD
CY2013Q1 vrng Adjustments To Additional Paid In Capital Conversion Of Derivative Warrants Into Equity Warrants
AdjustmentsToAdditionalPaidInCapitalConversionOfDerivativeWarrantsIntoEquityWarrants
0 USD
CY2014Q1 vrng Adjustments To Additional Paid In Capital Conversion Of Derivative Warrants Into Equity Warrants
AdjustmentsToAdditionalPaidInCapitalConversionOfDerivativeWarrantsIntoEquityWarrants
0 USD
vrng Adjustments To Additional Paid In Capital Conversion Of Derivative Warrants Into Equity Warrants
AdjustmentsToAdditionalPaidInCapitalConversionOfDerivativeWarrantsIntoEquityWarrants
3918000 USD
vrng Noncash Or Part Noncash Acquisition Working Capital Acquired
NoncashOrPartNoncashAcquisitionWorkingCapitalAcquired
740000 USD
vrng Noncash Or Part Noncash Acquisition Long Term Deposit Acquired
NoncashOrPartNoncashAcquisitionLongTermDepositAcquired
-8000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
-124000 USD
vrng Noncash Or Part Noncash Acquisition Goodwill Acquired
NoncashOrPartNoncashAcquisitionGoodwillAcquired
-65965000 USD
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
-10133000 USD
vrng Noncash Or Part Noncash Acquisition Fair Value Of Common Stock Acquired
NoncashOrPartNoncashAcquisitionFairValueOfCommonStockAcquired
58211000 USD
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Trading Symbol
TradingSymbol
VRNG
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
86531094 shares
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
Vringo Inc
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001410428
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1034000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
247000 USD
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
318000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
134000 USD
CY2013Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
3120000 USD
CY2014Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
974000 USD
CY2014Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1944000 USD
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
839000 USD
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
957000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6422000 USD
CY2014Q1 vrng Cost Method Investment Ownership Percentage
CostMethodInvestmentOwnershipPercentage
0.0825 pure
CY2013Q1 vrng Non Cash Acquisition Of Cost Method Investment
NonCashAcquisitionOfCostMethodInvestment
0 USD
CY2014Q1 vrng Non Cash Acquisition Of Cost Method Investment
NonCashAcquisitionOfCostMethodInvestment
787000 USD
vrng Non Cash Acquisition Of Cost Method Investment
NonCashAcquisitionOfCostMethodInvestment
787000 USD
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 USD
CY2014Q1 vrng Infringement Proceeding Value
InfringementProceedingValue
1400000 USD
CY2014Q1 vrng Deposited Amount For Surety Against Truth Of Allegations
DepositedAmountForSuretyAgainstTruthOfAllegations
900000 USD

Files In Submission

Name View Source Status
0001144204-14-028600-index-headers.html Edgar Link pending
0001144204-14-028600-index.html Edgar Link pending
0001144204-14-028600.txt Edgar Link pending
0001144204-14-028600-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v374817_10q.htm Edgar Link pending
v374817_ex31-1.htm Edgar Link pending
v374817_ex31-2.htm Edgar Link pending
v374817_ex32.htm Edgar Link pending
vrng-20140331.xml Edgar Link completed
vrng-20140331.xsd Edgar Link pending
vrng-20140331_cal.xml Edgar Link unprocessable
vrng-20140331_def.xml Edgar Link unprocessable
vrng-20140331_lab.xml Edgar Link unprocessable
vrng-20140331_pre.xml Edgar Link unprocessable